Zobrazeno 21 - 30
of 57
pro vyhledávání: '"Tapan M. Kadia"'
Autor:
Sherry Pierce, Gautam Borthakur, Michael Andreeff, Mark J. Levis, Guillermo Garcia-Manero, Keyur P. Patel, Elias Jabbour, Maro Ohanian, Jan A. Burger, Hagop M. Kantarjian, Farhad Ravandi, Jorge E. Cortes, Naval Daver, Tapan M. Kadia, Zeev Estrov, Mary Ann Richie
Publikováno v:
American Journal of Hematology. 93:1136-1141
Based on our previous study of the combination of sorafenib with 5-azacytidine (AZA) in relapsed/refractory patients with FLT3 mutated acute myeloid leukemia (AML), we hypothesized that the combination would be efficacious and well tolerated in untre
Autor:
Sanam Loghavi, Hagop M. Kantarjian, Jorge E. Cortes, Hussein A. Abbas, Nicholas J. Short, Ghayas C. Issa, Marina Konopleva, Gautam Borthakur, Tapan M. Kadia, Farhad Ravandi, Keyur P. Patel, Elias Jabbour, Koichi Takahashi
Publikováno v:
American Journal of Hematology. 94:E158-E160
Autor:
William G. Wierda, Nitin Jain, Jan A. Burger, Marina Konopleva, Alessandra Ferrajoli, Yasmin Abaza, Prithviraj Bose, Gautam Borthakur, Stefan Faderl, Deborah A. Thomas, Hind Al Azzawi, Farhad Ravandi, Naval Daver, Jorge E. Cortes, Mary A. Kelly, Partow Kebriaei, Philip A. Thompson, Hagop M. Kantarjian, Yesid Alvarado, Guillermo Garcia-Manero, Rebecca Garris, Tapan M. Kadia, Naveen Pemmaraju, Bouthaina S. Dabaja, Susan O'Brien, Preetesh Jain, Elias Jabbour, Steven M. Kornblau, Joseph D. Khoury
Publikováno v:
American Journal of Hematology. 93:91-99
Nelarabine, a water soluble prodrug of 9-β-D-arabinofuranosylguanine (ara-G), is a T-cell specific purine nucleoside analogue. Given its activity in relapsed and refractory T acute lymphoblastic leukemia (T-ALL) and T lymphoblastic lymphoma (T-LBL),
Autor:
Hsiang Chun Chen, Abhishek Maiti, Paolo Strati, Zeev Estrov, Farhad Ravandi, Xuelin Huang, Sherry Pierce, Tapan M. Kadia, Bouthaina S. Dabaja, Elias Jabbour, Guillermo Garcia-Manero, Simon Abi Aad, Susan O'Brien, Naval Daver, Hagop M. Kantarjian, Jorge E. Cortes, Carlos E. Bueso-Ramos, Carol Bivins, Nicholas J. Short
Publikováno v:
American Journal of Hematology. 92:924-928
Central nervous system (CNS) relapse is uncommon in patients with acute myeloid leukemia (AML) with the use of high-dose cytarabine containing chemotherapy regimens. The clinical and molecular features associated with a higher risk of CNS relapse are
Autor:
Gautam Borthakur, Zeev Estrov, Jasleen K. Randhawa, Katherine P. Hearn, Hagop M. Kantarjian, May Daher, Steven R. Reyes, Kausar J. Jabbar, Carlos E. Bueso-Ramos, Naveen Pemmaraju, Juliana E. Hidalgo Lopez, Marina Konopleva, Guillermo Garcia-Manero, Tapan M. Kadia, Yue Wei
Publikováno v:
American Journal of Hematology. 92:674-682
Myelodysplastic syndromes (MDSs) are characterized by ineffective hematopoiesis and an increased risk of transformation. Few effective therapies are available for lower risk MDS patients, especially after the failure of hypomethylating agents. MDS pr
Autor:
Elias Jabbour, Tapan M. Kadia, Koichi Takahashi, Marina Konopleva, Ana Alfonso, Zeev Estrov, BA Sherry Pierce Bsn, Farhad Ravandi, Carlos E. Bueso-Ramos, Guillermo Garcia-Manero, Gautam Borthakur, Naveen Pemmaraju, Hagop M. Kantarjian, Jorge E. Cortes, Guillermo Montalban-Bravo
Publikováno v:
American Journal of Hematology. 92:599-606
Hypomethylating agents (HMA) are the most commonly used therapeutic intervention in chronic myelomonocytic leukemia (CMML). Due to the lack of CMML-specific clinical trials, the impact of these agents in the natural history of CMML is not fully under
Autor:
Naval Daver, Zeev Estrov, Qiao Wei, Elias Jabbour, Simon Abi Aad, Farhad Ravandi, Simona Colla, Paolo Strati, Yue Wei, Guillermo Garcia-Manero, Susan O'Brien, Courtney D. DiNardo, Tapan M. Kadia, Jianhua Hu, Monica Cabrero, Gautam Borthakur, William G. Wierda, Carlos E. Bueso-Ramos, Hagop M. Kantarjian, Jorge E. Cortes, Nicholas J. Short
Publikováno v:
American Journal of Hematology. 92:351-358
Two hundred and sixteen consecutive patients with MDS and abnormal karyotype treated with hypomethylating agents between 4/04 and 10/12 were reviewed. Median follow-up was 17 months. Using IWG criteria, best responses were complete response (CR) in 7
Autor:
C. Cameron Yin, Ghayas C. Issa, Naval Daver, Hagop M. Kantarjian, Nitin Jain, Koji Sasaki, Rebecca Garris, Jorge E. Cortes, Heidi Ko, Christopher B. Benton, Guillermo Garcia-Manero, Keyur P. Patel, Nicholas J. Short, Maria Khouri, Elias Jabbour, Susan O'Brien, Farhad Ravandi, Deborah A. Thomas, Tapan M. Kadia, Marina Konopleva
Publikováno v:
American Journal of Hematology. 92:238-243
In patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) treated with chemotherapy plus a tyrosine kinase inhibitor (TKI), the prognostic impact of additional chromosomal abnormalities (ACAs) is not well-established.
Autor:
Marina Konopleva, Farhad Ravandi, Hagop M. Kantarjian, Jorge E. Cortes, Sherry Pierce, Guillermo Garcia-Manero, Naveen Pemmaraju, Nitin Jain, Tapan M. Kadia, Elias Jabbour, Jeffrey L. Jorgensen, Deborah A. Thomas, Sa A. Wang, Sergej Konoplev, Xuemei Wang, Susan O'Brien, Xuelin Huang, Rebecca Garris
Publikováno v:
American Journal of Hematology. 92:279-285
We sought to determine the significance of minimal residual disease (MRD) relapse in patients with ALL after achieving MRD negative status following induction and consolidation therapy. Between January 2003 and September 2014, 647 newly diagnosed pat
Autor:
Farhad Ravandi, Sherry Pierce, Susan O'Brien, Guillermo Garcia-Manero, Rebecca Garris, Sa Wang, Naveen Pemmaraju, Michael Rytting, Elias Jabbour, Steven M. Kornblau, Anna Franklin, Deborah A. Thomas, Gautam Borthakur, Hagop M. Kantarjian, Jorge E. Cortes, Alessandra Ferrajoli, Jeffrey L. Jorgensen, Marina Konopleva, Kurt Schroeder, Naval Daver, Tapan M. Kadia
Publikováno v:
American Journal of Hematology. 91:819-823
Several studies reported improved outcomes of adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL) treated with pediatric-based ALL regimens. This prompted the prospective investigation of a pediatric Augmented Berlin-Frankfurt-